Carolina Cannabinoids was formed through the collaboration of Bio Medical Engineers and Physicians. We are located at the Nevada Center for Applied Research in the University of Nevada, Reno.
Carolina Cannabinoids strives to develop formulations that activate Peroxisome Proliferator-Activated Receptors (PPARs). We simultaneously evaluate the modulation efficacy of Cannabinoids on Brainwaves for healing Neurological Disorders such as Addiction, Pain, Depression and Anxiety. We work collaboratively with researchers in the field of Computational Neuroscience from Swartz Center for Computational Neuroscience at University of California, San Diego. We utilize our engineering skills to model Neurological Disorders as captured by high-dimensional EEG and Artificial Intelligence models.
Carolina Cannabinoids was founded by Barany Jeganatth. Barany holds a Bachelor of Science degree in Mechanical Engineering, from the University of Saskatchewan in Canada. He had a successful career as an Engineer at Shell in Canada prior to starting Carolina Cannabinoids. Barany is an avid long-distance runner and swimmer. He runs a half marathon every week.
Dr. Eric Ehlenberger MD is our external medical collaborator. Dr. Ehlenberger collaborates with Carolina Cannabinoids to conduct clinical trials and to develop EEG based Artificial Intelligence models to quantify Neurological Disorders. Dr. Ehlenberger attended medical school at University of Southern California obtaining his MD degree. He is advanced certified in Pain Management by the American Academy of Pain Management and is certified by the American Board of Addiction Medicine. On a more personal note, Dr. Ehlenberger enjoys art with a particular interest in abstract sculpture. Paralleling his medical career, he has pursued a career as a sculptor working in neon, glass and metal. His sculpture career has included a number of private gallery and museum exhibitions throughout the United States, Europe and Japan.